Psychiatric comorbidities and schizophrenia

Schizophrenia Bulletin

Volumn 35, Issue 2, 2009, Pages 383-402

  Buckley, Peter F ^a   Miller, Brian J ^a   Lehrer, Douglas S ^b   Castle, David J ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Comorbidity; Schizophrenia; Substance abuse

Indexed keywords

ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; HUMAN; MORBIDITY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHENOTYPE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE;

COGNITION DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; STRESS DISORDERS, POST-TRAUMATIC; TERMINOLOGY AS TOPIC;

EID: 65149097825     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn135     Document Type: Article

References (206)

1. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT, Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58:165-171.
2. Pincus HA, Tew D, First MB. Psychiatric comorbidity: is more less? World Psychiatry. 2004;3:18-23.
3. Green AI, Canuso C, Brenner MJ, Wijcik JD. Detection and management of comorbidity in schizophrenia. Psychiatr Clin N Am. 2003;26:115-139.
4. Siris S, Bench C. Depression and schizophrenia. In: Hirsch S, Weinberger D, eds. Schizophrenia. 2nd ed. Oxford, UK: Blackwell; 2003:142-167.
5. Moller HJ. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses. 2007;1:328-340.
6. Kendell RE. The classification of depressions: a review of contemporary confusion. Br J Psychiatry. 1976;129:15-28.
7. Pierre JM. Deconstructing schizophrenia for DSM-V: challenges for clinical and research agendas. Clin Schizophr Relat Psychoses. 2008;2:166-174.
8. Wing J, Agrawal N. Concepts and classification of schizophrenia. In: Hirsch S, Weinberger D, eds. Schizophrenia. 2nd ed. Oxford, UJK: Blackwell; 2003:3-14.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
10. Buckley PF. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J. Clin Psychiatry. 2006;67:5-9.
11. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-0-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry. 2005;57: 1117-1127.
12. Bermanzohn PC, Porto L, Arlow PB, Pollack S, Stronger R, Siris SG. Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull. 2000;26:517-525.
13. Pokos V, Castle DJ. Prevalence of comorbid anxiety disorders in schizophrenia spectrum disorders: a literature review. Curr Psychiatry Rev. 2006;2:285-307.
14. Boyd JH. Use of mental health services for the treatment of panic disorder. Am J Psychiatry. 1986;143:1569-1574.
15. Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr Res. 2002;58:213-220.
16. Boyd JH, Burke JD, Jr, Gruenberg E, et al. Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry. 1984;41:983-989.
17. Robins LN, Regier DA, eds. Psychiatric Disorders in America: the Epidemiological Catchment Area Study. New York, NY: The Free Press; 1991.
18. Argyle N. Panic attacks in chronic schizophrenia. Br J Psychiatry. 1990;157:430-433.
19. Baylé FJ, Krebs MO, Epelbaum C, Levy D, Hardy P. Clinical features of panic attacks in schizophrenia. Eur Psychiatry. 2001;16:349-353.
20. Bland RC, Newman SC, Orn H. Schizophrenia: lifetime co-morbidity in a community sample. Acta Psychiatr Scand. 1987;75:383-391.
21. Cassano GB, Pini S, Saettoni M, Rucci P, Dell-Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J. Clin Psychiatry. 1998;59:60-68.
22. Chen CY, Liu CY, Yang YY. Correlation of panic attacks and hostility in chronic schizophrenia. Psychiatry Clin Neu-rosci. 2001;55:383-387.
23. Ciapparelli A, Paggini R, Marazziti D, et al. Comorbidity with axis I anxiety disorders in remitted psychotic patients 1 year after hospitalization. CNS Spectr. 2007;12:913-919.
24. Craig T, Hwang MY, Bromet EJ. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry. 2002; 159:592-598.
25. Cosoff SJ, Hafner RJ. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Aust N Z J Psychiatry. 1998;32:67-72.
26. Cutler JL, Siris SG. "Panic-like" symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications. Compr Psychiatry. 1991;32:465-473.
27. Garvey M, Noyes R, Jr, Anderson D, Cook B. Examination of comorbid anxiety in psychiatric inpatients. Compr Psychiatry. 1991;32:277-282.
28. Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res. 2003;61:89-95.
29. Heun R, Maier W. Relation of schizophrenia and panic disorder: evidence from a controlled family study. Am J Med Genet. 1995;60:127-132.
30. Higuchi H, Kamata M, Yoshimoto M, Shimisu T, Hishika-wa Y. Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment. Psychiatry Clin Neurosci. 1999;53:91-94.
31. Labbate LA, Young PC, Arana GW. Panic disorder in schizophrenia. Can J Psychiatry. 1999;44:488-490.
32. Lyons MJ, Huppert J, Toomey R, et al. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia. Twin Res. 2000;3:28-32.
33. Moorey H, Soni SD. Anxiety symptoms in stable chronic schizophrenics. J Ment Health. 1994;3:257-262.
34. Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry. 2004;161:53-58.
35. Strakowski SM, Tohen M, Stoll AL, et al. Comorbidity in psychosis at first hospitalization. Am J Psychiatry. 1993;150:752-757.
36. Tibbo P, Swainson J, Chue P, LeMelledo JM. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depress Anxiety. 2003;17:65-72.
37. Ulas H, Alptekin K, Akdede BB, et al. Panic symptoms in schizophrenia: comorbidity and clinical correlates. Psychiatry Clin Neurosci. 2007;61:678-680.
38. Zarate R. The comorbidity between schizophrenia and anxiety disorders. Paper presented at: 31st Annual Meeting of the Association for Advancement of Behavior Therapy. Miami Beach: Fla; November 1997.
39. Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL. Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res. 2005;39:409-414.
40. Katerndahl DA, Realini JP. Lifetime prevalence of panic states. Am J Psychiatry. 1993;150:246-249.
41. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-ΓV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin Psychiatry. 2006;67:363-374.
42. Tien AY, Eaton WW. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry. 1992;49:37-46.
43. Bermanzohn PC, Arlow PB, Pitch RJ, Siris SG. Panic and paranoia. J. Clin Psychiatry. 1997;58:325-326.
44. Hofmann SG. Relationship between panic and schizophrenia. Depress Anxiety. 1999;9:101-106.
45. Siris SG, Mason SE, Shuwall MA. Histories of substance abuse, panic and suicidal ideation in schizophrenic patients with histories of post-psychotic depression. Prog Neuropsy-chopharmacol Biol Psychiatry. 1993;17:609-617.
46. Fialko L, Freeman D, Bebbington P, et al. Understanding suicidal ideation in psychosis: findings from the psychological prevention of relapse in psychosis (PRP) trial. Acta Psychiatr Scand. 2006;114:177-186.
47. Weissman MM, Fyer AJ, Haghighi F, et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet. 2000;96:24-35.
48. Shi J, Badner JA, Gershon ES, Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res. 2008;98:89-97.
49. Morgan C, Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma-a critical review. Schizophr Bull. 2007;33:3-10.
50. Shaw K, McFarlane AC, Bookless C, Air T. The etiology of postpsychotic posttraumatic stress disorder following a psychotic episode.J. Trauma Stress. 2002;15:39-46.
51. Kennedy BL, Dhaliwal N, Pedley L, Sahner C, Greenberg R, Manshadi MS. Post-traumatic stress disorder in subjects with schizophrenia and bipolar disorder. J. Ky Med Assoc. 2002;100:395-399.
52. Frame L, Morrison AP. Causes of posttraumatic stress disorder in psychotic patients. Arch Gen Psychiatry. 2001;58: 305-306.
53. McGorry PD, Chanen A, McCarthy E, Van Riel R, McKen-zie D, Singh BS. Posttraumatic stress disorder following recent-onset psychosis. An unrecognized postpsychotic syndrome. J Nerv Ment Dis. 1991;179:253-258.
54. Shaw K, McFarlane A, Bookless C. The phenomenology of traumatic reactions to psychotic illness.J. Nerv Ment Dis. 1997;185:434-441.
55. Calhoun PS, Stechuchak KM, Strauss J, Bosworth HB, Marx CE, Butterfield MI. Interpersonal trauma, war zone exposure, and posttraumatic stress disorder among veterans with schizophrenia. Schizophr Res. 2007;91:210-216.
56. Fan X, Henderson DC, Nguyen DD, et al. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Res. 2008;159:140-146.
57. Gearon JS, Kaltman SI, Brown C, Bellack AS. Traumatic life events and PTSD among women with substance use disorders and schizophrenia. Psychiatr Serv. 2003;54:523-528.
58. Kilcommons AM, Morrison AP. Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatr Scand. 2005; 112:351-359.
59. Meyer H, Taiminen T, Vuori T, Aijälä A, Helenius H. Post-traumatic stress disorder symptoms related to psychosis and acute involuntary hospitalization in schizophrenic and delusional patients. J Nerv Ment Dis. 1999;187:343-352.
60. Mueser KT, Goodman LB, Trumbetta SL, et al. Trauma and posttraumatic stress disorder in severe mental illness.J. Consult Clin Psychol. 1998;66:493-499.
61. Mueser KT, Salyers MP, Rosenberg SD, et al. 5 Site Health and Risk Study Research Committee. Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates. Schizophr Bull. 2004;30:45-57.
62. Neria Y, Bromet EJ, Sievers S, Lavelle J, Fochtmann LJ. Trauma exposure and posttraumatic stress disorder in psychosis: findings from a first-admission cohort. J. Consult Clin Psychol. 2002;70:246-251.
63. Priebe S, Bröker M, Gunkel S. Involuntary admission and posttraumatic stress disorder symptoms in schizophrenia patients. Compr Psychiatry. 1998;39:220-224.
64. Resnick SG, Bond GR, Mueser KT. Trauma and posttraumatic stress disorder in people with schizophrenia. J Abnorm Psychol. 2003;112:415-423.
65. Seedat S, Fritelli V, Oosthuizen P, Emsley RA, Stein DJ. Measuring anxiety in patients with schizophrenia. J. Nerv Ment Dis. 2007;195:320-324.
66. Strakowski SM, Keck PE, Jr, McElroy SL, LonczakHS, West SA. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry. 1995;36:106-112.
67. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
68. Strauss JL, Calhoun PS, Marx CE, et al. Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder. Schizophr Res. 2006;84:165-169.
69. Calhoun PS, Bosworth HB, Stechuchak KA, Strauss J, But-terfield MI. The impact of posttraumatic stress disorder on quality of life and health service utilization among veterans who have schizophrenia.J. Trauma Stress. 2006;19:393-397.
70. Scheller-Gilkey G, Moynes K, Cooper I, Kant C, Miller AH. Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr Res. 2004;69:167-174.
71. Goodman C, Finkel B, Naser M, et al. Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD. J Nerv Ment Dis. 2007; 195:415-420.
72. Berman I, Kalinowski A, Berman SM, Lengua J, Gren AL Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995;36:6-10.
73. Eisen JL, Beer DA, Pato MT, Venditto TA, Rasmussen SA. Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry. 1997; 154: 271-273.
74. Fabisch K, Fabisch H, Langs G, Wieselmann G, Zapo-toczky HG. Obsessive-compulsive symptoms in schizophrenia. Schizophr Res. 1997;24:15.
75. Fabisch K, Fabisch H, Langs G, Huber HP, Zapotoczky HG. Incidence of obsessive-compulsive phenomena in the course of acute schizophrenia and schizoaffective disorder. Schizophr Res. 2001;16:336-341.
76. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437-441.
77. Karno M, Golding JM, Sorensen SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094-1099.
78. Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D. Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005;59: 291-295.
79. Krüger S, Bräunig P, Höffler J, Shugar G, Börner I, Langk-rär J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J N'euro-psychiatry Clin Neurosci. 2000;12:16-24.
80. Meghani SR, Penick EC, Nickel EJ. Schizophrenia patients with and without OCD. Paper presented at: 151st Annual Meeting of the American Psychiatric Association. Toronto, ON; May, 1998.
81. Mohammadi MR, Ghanizadeh A, Moini R. Lifetime comorbidity of obsessive-compulsive disorder with psychiatric disorders in a community sample. Depress Anxiety. 2007;24:602-607.
82. Nechmad A, Ratzoni G, Poyurovsky M, et al. Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry. 2003;160:1002-1004.
83. Porto L, Bermanzohn PC, Pollack S, Morrissey R, Siris SG. A profile of obsessive-compulsive symptoms in schizophrenia. CNS Spectrum. 1997;2:21-25.
84. Poyurovsky MD, Fuchs C, Weizman A. Obsessive-compulsive disorder in patients with first-episode schizophrenia. Am J Psychiatry. 1999;156:1998-2000.
85. Poyurovsky M, Hramenkov S, Isakov V. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001;102:49-57.
86. Tibbo P, Kroetsch M, Chue P, Warneke L. Obsessive-compulsive disorder in schizophrenia.J. Psychiatr Res. 2000;34: 139-146.
87. Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci. 1999;24:15-24.
88. Lucka I, Fryze M, Cebella A, Staszewsak E. Prodromal symptoms of schizophrenics syndrome in children and adolescents. Psychiatr Pol. 2002;36(suppl):283-286.
89. Iida J, Iwasaka H, Hirao F, et al. Clinical features of childhood-onset schizophrenia with obsessive-compulsive symptoms during the prodromal phase. Psychiatry Clin Neurosci. 1995;49:201-207.
90. Shioiri T, Shinada K, Kuwabara H, Someya T. Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia. Psychiatry Clin Neurosci. 2007;61:348-354.
91. Poyurovsky M, Faragian S, Shabeta A, Kosov A. Comparison of clinical characteristics, co-morbidity and pharmaco-therapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 2008;159:133-139.
92. Poyurovsky M, Fuchs C, Faragian S, et al. Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry. 2006;51:746-754.
93. Rajkumar RP, Reddy YC, Kandavel T. Clinical profile of "schizo-obsessive" disorder: a comparative study. Compr Psychiatry. 2008;49:262-268.
94. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AL Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J. Nerv Merit Dis. 1998;186:150-156.
95. Whitney KA, Fastenau PS, Evans JD, Lysaker PH. Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophr Res. 2004;69: 75-83.
96. Sevincok L, Akoglu A, Kokcu F. Suicidality in schizophrenia patients with and without obsessive-compulsive disorder. Schizophr Res. 1002;90:198-202.
97. Poyurovsky M, Kriss V, Weisman G, et al. Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD. Am J Med Genet B Neuropsychiatr Genet. 2005;133:31-36.
98. Poyurovsky M, Michaelovsky E, Frisch A, et al. COMT Vall58Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci Lett. 2005;389:21-24.
99. Bottas A, Cooke RG, Richter MA. Comorbidity and path-ophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005;30:187-193.
100. Mahendran R, Liew E, Subramaniam M. De novo emergence of obsessive-compulsive symptoms with atypical anti-psychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study. J. Clin Psychiatry. 2007;68:542-545.
101. Ertugrul A, Anil Yagcioglu AE, Eni N, Yazici KM. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005;59(2):219-22.
102. Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005;10(5):356-61.
103. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive-compulsive symptoms induced by atypical anti-psychotics. A review of the reported cases. Prog Neuropsy-chopharmacol Biol Psychiatry. 2003;27(3):333-46.
104. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsy-chotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11(7):622-32.
105. Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.J. Clin Psychiatry. 2004;65(8):1040-8.
106. Bystritsky A, Ackerman DL, Rosen RM, Vapnik T, Gorbis E, Maidment KM, Saxena S. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. J. Clin Psychiatry. 2004;65(4):565-8.
107. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR. The use of aripiprazole in obsessive-compulsive disor- der: preliminary observations in 8 patients. J. Clin Psychiatry. 2005;66(1):49-51.
108. Taylor MA. Are schizophrenia and affective disorder related? A selective literature review. Am J Psychiatry. 1992;149:22-32.
109. Walker J, Curtis V, Murray RM. Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment. Int Clin Psychopharmacol. 2002;17(Suppl. 3):S11-19.
110. Ketter TA, Wang PW, Becker OV, .Nowakowska C, Yang Y. Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?J. Psychiatr Res. 2004;38:47-61.
111. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull. 2006;32:9-16.
112. Raymond Lake C. Disorders of thought are severe mood disorders: the selective attention defect in mania challenges the Kraepelinian dichotomy a review. Schizophr Bull. 2008; 34:109-117.
113. Moller HJ. Occurrence and treatment of depressive comor-bidity/ cosyndromality in schizophrenic psychoses: conceptual and treatment issues. World J Biol Psychiatry. 2005;6: 247-263.
114. Bartels SJ, Drake RE. Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry. 1988;29:467-483.
115. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county. Sweden. Schizophr Res. 2000;45:21-28.
116. Westermeyer J. Comorbid schizophrenia and substance abuse: a review of epidemiology and course. Am J Addict. 2006;15:345-355.
117. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Casey E. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry. 1988; 145:1532-1537.
118. Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002;36: 733-742.
119. Kudo J, Mori H, Gomibuchi T. Loneliness as expressed by schizophrenic patients in the early remission phase. Nagoya J Med Sci. 2002;65:115-126.
120. Roth S. The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. Am J Psychiatry. 1970;127:51-58.
121. Knights A, Hirsch SR. "Revealed" Depression and drug treatment for schizophrenia. Arch Gen Psychiatry. 1981;38: 806-811.
122. Baynes D, Mulholland C, Cooper SJ, Montgomery RC, et al. Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res. 2000;45:47-56.
123. Herz M. Prodromal symptoms and prevention of relapse in schizophrenia.J. Clin Psychiatry. 1985;46:22-25.
124. Mandel MR, Severe JB, Schooler NR, Gelenberg AJ, Mieske M. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry. 1982;39:197-203.
125. Johnson DA. The significance of depression in the prediction of relapse in chronic schizophrenia. Br J Psychiatry. 1988;152:320-323.
126. Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry. 1993;150: 1182-1188.
127. Sim K, Chan YH, Chong SA, Siris SG. A 24-month prospective outcome study of first-episode schizophrenia and schizoaffective disorder within an early psychosis intervention program.J. Clin Psychiatry. 2007;68:1368-1376.
128. McGlashan TH, Carpenter WT, Jr. An investigation of the postpsychotic depressive syndrome. Am J Psychiatry. 1976; 133:14-19.
129. Weissman MM, Pottenger M, Kleber H, Ruben HL, Williams D, Thompson WD. Symptom patterns in primary and secondary depression. A comparison of primary depres-sives with depressed opiate addicts, alcoholics, and schizophrenics. Arch Gen Psychiatry. 1977;34:854-862.
130. Van Putten T, May RP. "Akinetic depression" in schizophrenia. Arch Gen Psychiatry. 1978;35:1101-1107.
131. Knights A, Okasha MS, Salih MA, Hirsch SR. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Br J Psychiatry. 1979;135:515-523.
132. Johnson DA. Studies of depressive symptoms in schizophrenia. Br J Psychiatry. 1981;139:89-101.
133. Siris SG, Harmon GK, Endicott J. Postpsychotic depressive symptoms in hospitalized schizophrenic patients. Arch Gen Psychiatry. 1981;38:1122-1123.
134. Roy A. Depression in the course of chronic undifferentiated schizophrenia. Arch Gen Psychiatry. 1981;38:296-297.
135. Moller HJ, von Zerssen D. Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull. 1982;8:109-117.
136. Guze SB, Cloninger CR, Martin RL, Clayton PJ. A follow-up and family study of schizophrenia. Arch Gen Psychiatry. 1983;40:1273-1276.
137. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Frequency and differential diagnosis of depressive syndromes in schizophrenia. J. Clin Psychiatry. 1985;46:9-13.
138. Summers F, Harrow M, Westermeyer J. Neurotic symptoms in the postacute phase of schizophrenia. J. Nerv Ment Dis. 1983;171:216-221.
139. Roy A. Depression, attempted suicide, and suicide in patients with chronic schizophrenia. Psychiatr Clin North Am. 1986;9:193-206.
140. Munro JG, Hardiker TM, Leonard DP. The dexamethasone suppression test in residual schizophrenia with depression. Am J Psychiatry. 1984;141:250-252.
141. Elk R, Dickman BJ, Teggin AF. Depression in schizophrenia: a study of prevalence and treatment. Br J Psychiatry. 1986;149:228-229.
142. Leff J, Tress K, Edwards B. The clinical course of depressive symptoms in schizophrenia. Schizophr Res. 1988;1:25-30.
143. Johnson DA. The significance of depression in the prediction of relapse in chronic schizophrenia. Br J Psychiatry. 1988;152:320-323.
144. Kulhara P, Avasthi A, Chadda R, Chandiramani K, Mattoo SK, Kota SK, Joseph S. Negative and depressive symptoms in schizophrenia. Br J Psychiatry. 1989;154:207-211.
145. Hirsch SR, Jolley AG. The dysphoric syndrome in schizophrenia and its implications for relapse. Br J Psychiatry. 1989;(Suppl):46-50.
146. Barnes TR, Curson DA, Liddle PF, Patel M. The nature and prevalence of depression in chronic schizophrenic in-patients. Br J Psychiatry. 1989;154:486-491.
147. Bandelow B, Muller P, Gaebel W, Kopcke W, Linden M, Muller-Spahn F, Pietzcker A, Reischies FM, Tegeler J. Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Dusseldorf, Got-tingen, Munich. Eur Arch Psychiatry Clin Neurosci. 1990; 240:113-120.
148. Addington D, Addington J. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia. Can J Psychiatry. 1990;35:430-433.
149. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry. 1991;48:239-246.
150. Lindenmayer JP, Grochowski S, Kay SR. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms. Compr Psychiatry. 1991; 32:528-533.
151. Birchwood M, Mason R, MacMillan F, Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med. 1993;23: 387-395.
152. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lie-berman J. Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150:1643-1648.
153. Tapp A, Tandon R, Douglass A, Dudley E, Scholten R, Underwood M. Depression in severe chronic schizophrenia. Biol Psychiatry. 1994;35:667.
154. Harrow M, Yonan CA, Sands JR, Marengo J. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr Bull. 1994;20:327-338.
155. Mauri MC, Bravin S, Fabiano L, Vanni S, Boscati L, Invernizzi G. Depressive symptoms and schizophrenia a psychopharmacological approach. Encephale. 1995;21: 555-558.
156. Markou P. Depression in schizophrenia: a descriptive study. Aust N Z J Psychiatry. 1996;30:354-357.
157. Wassink TH, Flaum M, Nopoulos P, Andreasen NC. Prevalence of depressive symptoms early in the course of schizophrenia. Am J Psychiatry. 1999;156:315-316.
158. Muller MJ, Wetzel H. Dimensionality of depression in acute schizophrenia: a methodological study using the Bech-Rafaelsen Melancholia Scale (BRMES).J. Psychiatr Res. 1998;32:369-378.
159. Sands JR, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull. 1999;25: 157-171.
160. Zisook S, McAdams LA, Kuck J, Harris MJ, Bailey A, Patterson TL, Judd LL, Jeste DV. Depressive symptoms in schizophrenia. Am J Psychiatry. 1999;156:1736-1743.
161. Baynes D, Mulholland C, Cooper SJ, Montgomery RC, MacFlynn G, Lynch G, Kelly C, King DJ. Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res. 2000;45:47-56.
162. Bottlender R, Strauss A, Moller HJ. Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res. 2000;44: 145-150.
163. Bressan RA, Chaves AC, Pilowsky LS, Shirakawa I, Mari JJ. Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Res. 2003;117:47-56.
164. Serretti A, Mandelli L, Lattuada E, Smeraldi E. Depressive syndrome in major psychoses: a study on 1351 subjects. Psychiatry Res. 2004;127:85-99.
165. Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77:11-24.
166. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry. 2002;159:1855-1861.
167. Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry. 1991;48: 1075-1081.
168. Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77:11-24.
169. Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand. 1999;100:105-118.
170. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
171. Schothorst PF, Emck C, van Engeland H. Characteristics of early psychosis. Compr Psychiatry. 2006;47:438-442.
172. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull. 2003;29: 633-651.
173. Baxter LR, Jr., Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989;46: 243-250.
174. Sackeim HA, Prohovnik I, Moeller JR, Brown RP, Apter S, Prudic J, Devanand DP, Mukherjee S. Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry. 1990;47:60-70.
175. Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry. 1993;162: 183-192.
176. Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry. 2003;53:376-384.
177. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004;161: 598-607.
178. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004; 161:1957-1966.
179. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005;162:2233-2245.
180. Boks MP, Hoogendoorn M, Jungerius BJ, Bakker SC, Sommer IE, Sinke RJ, Ophoff RA, Kahn RS. Do mood symptoms subdivide the schizophrenia phenotype? association of the GMP6A gene with a depression subgroup. Am J Med Genet B Neuropsychiatr Genet. 2007.
181. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci. 2003;985:420-444.
182. Paradiso S, Andreasen NC, Crespo-Facorro B, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Emotions in un-medicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry. 2003;160:1775-1783.
183. Siris SG. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. Am J Psychiatry. 2000; 157:1379-1389.
184. Tollefson GD, Sanger Tm, Lu Y, Thieme ME. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry. 1998;55(3):250-258.
185. Marder SR, Davis JM, Chouinard G. The effects of risper-idone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.J. Clìn Psychiatry. 1997;58(12):538-546.
186. Emsley R, Buckley PF, Jones AM, Greenwood MR. Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia. Journal of Psychopharmacology. 2003;17(2):205-210.
187. Meltzer Hy, Alphs L, Green AI, Altamura C, ANad R, Ber-toldi A, et al. International suicide prevention trial study group. Clozapine treatment for suicidality in schizophrenia: International suicide prevention trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91.
188. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive
189. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.J. Clin Psychiatry. 2007;68(4):546-57.
190. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
191. Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurrence of DSMIII-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Study. Arch Gen Psychiatry. 1997;54:313-321.
192. Merikangas KR, Ames M, Lui L. The impact of comorbidity of mental and physical conditions on sole disability in the US adult household population. Arch Gen Psychiatry. 2007;64(10):1180-1188.
193. O' Daly OG, Guillin, Tsapakis EM, et al. Schizophrenia and substance abuse comorbidity: a role for dopamine sensitiza-tion? Journal of Dual Diagnosis. 2005;l(2):ll-40.
194. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet. 2007;370(95840): 319-328.
195. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325(7374):1199.
196. Boydell J, Dean K, Dutta R, et al. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cvannabis psychosis. Schizophrenia Res. 2007;93(l-3): 203-210.
197. Caton CL, Drake RE, Hasin DS, et al. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry. 2005;62(2): 137-45.
198. Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694-701.
199. Chambers RA, Bickel WK, Potenza MN. A scale-free systems theory of motivation and addiction. Neuroscj Biobehav Rev. 2007;31:1017-1045.
200. Dixon L, Haas G, Weiden PJ, et al. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophrenia Bulletin. 1990;16: 69-79.
201. Voruganti LNP, Heslegrave RJ, Awad AG. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J. Nerv Ment Dis. 1997;185: 463-65.
202. Green Al, Noordsy DL, Burnette MF, et al. Substance abuse and schizophrenia: pharmacotherapeutic interventions.J. Subst Abuse Treat. 2008;34:61-71.
203. Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psych Clin North Am. 2007;30(3):437-452.
204. Swartz MS, Wagner HR, Swanson JW, et al. The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study. Schizophr Res. 2008; 100(1-3):39-35.
205. Drake RE, Xie H, McHugo GJ, et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bulletin. 2000;26(2):441-9.
206. Cascade E, Kalali A, Buckley PF. Current management of schizophrenia: antipsychotic monotherapy versus combination therapy. Psychiatry. 2008;5(5):28-30.